videos

  • Payer insights for cell and gene therapies2:29

    Payer insights for cell and gene therapies

    It is essential to address the payer landscape very early in development for a product administered once with a lifelong effect, such as a gene therapy. The one-time, front-loaded costs of these treat

    Watch Video
  • Maximizing your virtual investigator meeting results2:28

    Maximizing your virtual investigator meeting results

    Learn how Parexel brings the principles and energy from face-to-face investigator meetings to an interactive and engaging virtual environment.

    Watch Video
  • CAR-T: A patient’s cell therapy success story7:35

    CAR-T: A patient’s cell therapy success story

    Clinical trials of (CAR) T-cell therapies can present unprecedented enrolment challenges. How can we encourage participation in these trials? Doug Olson, one of the first CAR-T patients treated on a

    Watch Video
  • Parexel on the pulse2:08

    Parexel on the pulse

    Parexel regulatory expert, Mark Birse, gives an update on BREXIT.

    Watch Video
  • Impact of Real-World Evidence on Payers & Patients3:29

    Impact of Real-World Evidence on Payers & Patients

    Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Howell, Executive Vice President, Chief Commercial & Strategy Officer and Sy Pretorius, Executi

    Watch Video
  • Real-World Evidence: The Feedback Loop3:18

    Real-World Evidence: The Feedback Loop

    RWE experts Leanne Larson, Senior Vice President and Worldwide Head, Real-World Evidence and Access and Amy McKee, Vice President, Regulatory and Access dig deeper into the evolving role of RWE.

    Watch Video
  • Accelerated Pathways – Alberto Grignolo2:55

    Accelerated Pathways – Alberto Grignolo

    Watch Video
  • FDA Quality Management Maturity Pilot Programs3:32

    FDA Quality Management Maturity Pilot Programs

    Parexel’s Paul Bridges, SVP Regulatory & Access and Lynne Ensor, Head of Global Compliance outline the benefits for drug manufacturers in participating in two new FDA pilot programs. These include API

    Watch Video
  • Parexel on the Pulse1:49

    Parexel on the Pulse

    Paul Bridges on the EU Clinical Trial Regulation (CTR)

    Watch Video
  • Genomics & biomarkers: Answers in the blood2:56

    Genomics & biomarkers: Answers in the blood

    Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi

    Watch Video
  • Patient registries: Defining the patient2:15

    Patient registries: Defining the patient

    Parexel’s Leanne Larson, Corporate VP and WW Head, Real-world Evidence speaks with Deborah Collyar, cancer survivor and President of Advocates in Research about the importance of Real-world Evidence (

    Watch Video
  • Innovation: Today’s patients, tomorrow’s medicines.3:04

    Innovation: Today’s patients, tomorrow’s medicines.

    Sy Pretorius, EVP and Chief Medical & Scientific Officer, Parexel and Gadi Saarony, CEO, Advarra discuss how industry-leading innovations help to reduce the time and cost of development, minimize the

    Watch Video
  • Leveraging Real-World Evidence in a Rare Disease Oncology Drug Approval1:21

    Leveraging Real-World Evidence in a Rare Disease Oncology Drug Approval

    Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-World Evidence and FDA/Regulatory expertise to develop and execute a Synthet

    Watch Video
  • Parexel Patient Advisory Council: EU Meeting2:29

    Parexel Patient Advisory Council: EU Meeting

    Watch Video
  • Rare Diseases: Aligning Expertise2:06

    Rare Diseases: Aligning Expertise

    See how Parexel are bringing together regulatory and market access experts to help companies developing rare and orphan disease products. Learn more about our Regulatory & Access Consulting Group: htt

    Watch Video
  • Parexel Biotech: The value of patient-centric approaches - escaping the clinic4:24

    Parexel Biotech: The value of patient-centric approaches - escaping the clinic

    Parexel’s Rosamund Round, Director, Patient Innovation Center and Amy McKee, Vice President, Regulatory Consulting Services sit down with Monica Theis, a breast cancer survivor and two-time clinical t

    Watch Video
  • Parexel Biotech – designed with biotech’s unique way of working in mind2:55

    Parexel Biotech – designed with biotech’s unique way of working in mind

    James Anthony, SVP, Global Head Biotech and Graciela Rácaro, SVP, Global Head, Biotech Operations, both from Parexel, discuss how Parexel Biotech has been built to meet customer and the patient needs

    Watch Video
  • Parexel dares to do its part #WithHeart1:10

    Parexel dares to do its part #WithHeart

    Watch Video
  • Navigating Global Regulatory Submissions3:00

    Navigating Global Regulatory Submissions

    Watch Video
  • Parexel® Regulatory Consulting Services3:20

    Parexel® Regulatory Consulting Services

    An overview of Parexel’s Regulatory Consulting services.

    Watch Video
  • loading
    Loading More...